Literature DB >> 26069248

Amplification of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma.

Tao Li1, Junjie Xie1, Chuan Shen1, Dongfeng Cheng1, Yuan Shi1, Zhichong Wu1, Xiaxing Deng1, Hao Chen1, Baiyong Shen1, Chenghong Peng1, Hongwei Li1, Qian Zhan1, Zhecheng Zhu2.   

Abstract

Despite progress in the diagnostics and treatment of hepatocellular carcinoma (HCC), its prognosis remains poor. In this study, we globally assessed long noncoding RNAs (lncRNA) for contributions to HCC using publicly available microarray data, in vitro and in vivo assays. Here, we report that ZFAS1, encoding a lncRNA that is frequently amplified in HCC, is associated with intrahepatic and extrahepatic metastasis and poor prognosis of HCC. ZFAS1 functions as an oncogene in HCC progression by binding miR-150 and abrogating its tumor-suppressive function in this setting. miR-150 repressed HCC cell invasion by inhibiting ZEB1 and the matrix metalloproteinases MMP14 and MMP16. Conversely, ZFAS1 activated ZEB1, MMP14, and MMP16 expression, inhibiting these effects of miR-150. Our results establish a function for ZFAS1 in metastatic progression and suggest its candidacy as a new prognostic biomarker and target for clinical management of HCC. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26069248     DOI: 10.1158/0008-5472.CAN-14-3721

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  143 in total

1.  LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma.

Authors:  Changsheng Shi; Qing Yang; Songsong Pan; Xingcheng Lin; Gending Xu; Ya Luo; Bingru Zheng; Xiangpang Xie; Mingxu Yu
Journal:  Cancer Biol Ther       Date:  2020-04-24       Impact factor: 4.742

Review 2.  Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.

Authors:  Chun-Ming Wong; Felice Ho-Ching Tsang; Irene Oi-Lin Ng
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-10       Impact factor: 46.802

3.  Upregulation of lncRNA Sox2ot indicates a poor prognosis for patients with hepatocellular carcinoma and promotes cell invasion.

Authors:  Ji Sun; Xiaomou Wei; Li Xu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 4.  Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Authors:  Jente van Staalduinen; David Baker; Peter Ten Dijke; Hans van Dam
Journal:  Oncogene       Date:  2018-07-12       Impact factor: 9.867

5.  A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.

Authors:  Po-Shun Wang; Cheng-Han Chou; Cheng-Han Lin; Yun-Chin Yao; Hui-Chuan Cheng; Hao-Yi Li; Yu-Chung Chuang; Chia-Ning Yang; Luo-Ping Ger; Yu-Chia Chen; Forn-Chia Lin; Tang-Long Shen; Michael Hsiao; Pei-Jung Lu
Journal:  Oncogene       Date:  2018-05-14       Impact factor: 9.867

Review 6.  The functional roles of exosomes-derived long non-coding RNA in human cancer.

Authors:  Feiyu Chen; Ning Wang; Hor-Yue Tan; Wei Guo; Cheng Zhang; Yibin Feng
Journal:  Cancer Biol Ther       Date:  2019-02-11       Impact factor: 4.742

Review 7.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

8.  LncRNA ZFAS1 promotes cell migration and invasion of fibroblast-like synoviocytes by suppression of miR-27a in rheumatoid arthritis.

Authors:  Yang Ye; Xiaomei Gao; Nanping Yang
Journal:  Hum Cell       Date:  2017-07-18       Impact factor: 4.174

9.  Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.

Authors:  Yuan Xue; Yan-Qing Teng; Jian-Dong Zhou; Yong-Jun Rui
Journal:  Tumour Biol       Date:  2015-08-18

10.  ZFAS1 knockdown inhibits fibroblast-like synoviocyte proliferation, migration, invasion and inflammation, and promotes apoptosis via miR-3926/FSTL1 in rheumatoid arthritis.

Authors:  Qiang Wang; Peigang Chu; Xia Yu; Jun Li; Wenzheng Zhang; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.